Company Filing History:
Years Active: 2010
Title: The Innovations of Christopher Depre
Introduction
Christopher Depre is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of cancer diagnostics and treatment. His innovative approach to identifying agents that modulate cell growth or survival has the potential to impact cancer therapies.
Latest Patents
Christopher Depre holds a patent for a method that identifies agents which modulate cell growth or survival. The patent, titled "Method for identifying agents which modulate cell growth or survival," involves a technique for identifying agents that affect the net ratio of nuclear-localized versus cytosolic-localized H11 kinase or mutant H11 kinase in a cell. This method also provides a way to diagnose cancers associated with H11 kinase or Akt activation in subjects. He has 1 patent to his name.
Career Highlights
Christopher is affiliated with the University of Medicine and Dentistry of New Jersey, where he conducts research and develops innovative methodologies. His work has garnered attention for its potential applications in cancer treatment and diagnostics.
Collaborations
One of his notable collaborators is Stephen F Vatner, with whom he has worked on various research projects aimed at advancing medical science.
Conclusion
Christopher Depre's contributions to the field of biomedical research exemplify the impact of innovation in healthcare. His patented methods for identifying agents that modulate cell growth are paving the way for advancements in cancer diagnostics and treatment.